An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
Special items: Ovarian Cancer and Us blog best viewed in Firefox
▼
Saturday, January 29, 2011
Lancet (abstract) Retraction: validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial
Note: full details available to subscribers ($$$)
Comment
Retraction—validation of gene signatures that predict the response of
breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC
10994/BIG 00-01 clinical trial
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.